Datasets Mentioned
BETA
GSE22845
GSE37642
GSE21261
GSE101751
Methods Mentioned
BETA
ChIP
flow cytometry
PMA
immunoprecipitation
PCR
Software Mentioned
FlowJo
Image Lab
Gene set enrichment analysis ( GSEA )
Affymetrix
Microarray Suite
Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
The Journal of Immunology : Official Journal of the American Association of Immunologists
Jonathan K AlderCurt I Civin
Molecular and Cellular Biology
Valerie A MorrisVivian G Oehler
Oncotarget
Wenwen LiXinyan Zhang
The EMBO Journal
Mark W FeinbergMukesh K Jain
Mechanisms of Development
R Behr, Klaus H Kaestner